Advertisement

Inhibition of hepatitis B virus–associated liver cancer by antiplatelet therapy: A revolution in hepatocellular carcinoma prevention?

Authors


  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary